Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Expert Opinion on Emerging Drugs|December 9, 2014
Emerging mAbs for the treatment of esophagogastric cancerGeoffrey Y Ku, David H IlsonGastroenterology Clinics of North America|March 31, 2009
Preoperative therapy for esophageal cancerGeoffrey Y Ku, David H IlsonThoracic Surgery Clinics|November 9, 2013
Adjuvant (postoperative) therapy for esophageal cancerGeoffrey Y Ku, David H IlsonSurgical Oncology Clinics of North America|June 9, 2009
Role of neoadjuvant therapy for esophageal adenocarcinomaGeoffrey Y Ku, David H IlsonSeminars in Radiation Oncology|December 5, 2012
Chemotherapeutic options for gastroesophageal junction tumorsGeoffrey Y Ku, David H IlsonExpert Opinion on Emerging Drugs|June 4, 2013
Emerging tyrosine kinase inhibitors for esophageal cancerGeoffrey Y Ku, David H IlsonClinical Advances in Hematology & Oncology : H&O|June 3, 2008
Preoperative therapy in esophageal cancerGeoffrey Y Ku, David H IlsonCancer Journal (Sudbury, Mass.)|July 11, 2007
Esophageal cancer: adjuvant therapyGeoffrey Y Ku, David H IlsonGastrointestinal Cancer Research : GCR|August 14, 2012
Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensusGeoffrey Y Ku, David H IlsonCancer Treatment Reviews|February 4, 2010
Esophagogastric cancer: targeted agentsGeoffrey Y Ku, David H IlsonPageof 18